Table 2. IgG responses.
| Group | Animal | MOG34–56 | CMVmcp981–1003 | cMOG34–56 | rhMOG |
| A (MOG34–56) | A1 | − | − | − | − |
| A2 | ++ | − | − | ++ | |
| A3 | − | − | − | − | |
| A4 | − | − | − | − | |
| A5 | +++ | − | + | +++ | |
| B (CMVmcp981–1003) | B1 | ++ | − | - | + |
| B2 | + | − | − | + | |
| B3 | − | +* | − | +* | |
| B4 | ++ | − | + | ++ | |
| B5 | ++ | − | + | ++ | |
| C (cMOG34–56) | C1 | − | − | − | +* |
| C2 | +* | +* | + * | + * | |
| C3 | − | − | − | − | |
| C4 | − | − | − | − | |
| C5 | − | − | − | − |
*
Positive responses developed before the booster immunization on day 98.
A positive antibody response was defined as the light absorbance at 405 nm being >1.5 times than the absorbance of the day-0 sample on at least two time points.